A HIBRIDAÇÃO IN SITU FLUORESCENTE (FISH) EM LEUCEMIA MIELÓIDE CRÔNICA (LMC)
|
(especial para SIIC © Derechos reservados) |
|
O FISH (hibridação in situ fluorescente) tem mostrado grandes vantagens em relação à citogenética clássica em determinadas situações, pela maior sensibilidade, especificidade e rapidez no diagnóstico. |
Resumen
O estudo das alterações cromossômicas através da análise do cariótipo é de fundamental importância no diagnóstico da leucemia mielóide crônica. Após o tratamento, técnicas moleculares como a hibridação in situ fluorescente (FISH) e a reação em cadeia da polimerase por transcriptase reversa (RT-PCR) também são importantes para monitorar doença residual. Hoje, estão disponíveis diferentes tipos de sondas para pesquisa do BCR/ABL e suas aplicações são aqui discutidas.
Palabras clave
Cromossomo Philadelphia, FISH
Clasificación en siicsalud
Artículos originales> Expertos del Mundo>
página www.siicsalud.com/des/des030/02n11000.htm
Especialidades
Principal: Hematología
Relacionadas: Oncología, Medicina Interna
Artículo completo (portugués)
Extensión:
+/- 3.95 páginas impresas en papel A4
Exclusivo para suscriptores/ assinantes |
Abstract
The study of chromosomal abnormalities by karyotype is of fundamental importance at the diagnosis of chronic myeloid leukemia. After treatment, molecular techniques like fluorescent in situ hybridization (FISH) as well as RT-PCR are also extremely important to monitor residual disease. Today different types of probes for BCR/ABL are available and their applicability is here discussed.
Key words
Philadelphia chromosome, FISH
Bibliografía del artículo
- Maserati E, Pasquali F, Peretti D.: Different break-point in Philadelphia variant translocation and in constitutional and sporadic translocations. Ann Hum Genet 1986 50:153-162.
- Chauffaille MLF, Perroud PR, Catelani ALM, Obelar MRE, Kusagari N, Abe KT: Leucemia mielóide crônica com cromossomo Phialdelphia variante: relato de 3 casos. Newslab 1999 7(37):58-60.
- Reddy KS, Sulcova V. A FISH study of variant Philadelphia rearrangements. Cancer Genet Cytogenet 2000 118: 121-131.
- Chauffaille MLLF, Romeo M, Kerbauy J: O papel da citogenética e do FISH nas leucemias agudas. Laes Haes 1997 109:114-8.
- Anastasi J, Feng J, Le Beau M, Larson R, Rowley JD, Vardiman JW: Cytogenentic clonality in SMD studied with FISH : lineage, response to growth factor therapy and clone expansion. Blood 1993 81(6): 1580-5.
- Varella-Garcia M: Assessing residual leukemia through FISH. Genetics and Mol Biol 1998 21(3): 323-7.
- Chauffaille MLLF, Oliveira JSR, Romeo M, Kerbauy J: FISH for BCR/ABL in CML after bone marrow transplantation SPaulo Med Journ 2001 119( 1 ):16-8.
- Dewald G, Wyatt W, Juneau A, Carlson R, Zinmeister A, Jalal S, Spurbeck J, Silver R: Highly sensitive fluoreescence in tiu hybridization method to detect double BCR/ABL fusion and monitor response to hterapy in CML. Blood 1998 91(9):3357-3365.
- Sincalir P, Nacheva E, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B, Green A Large deletions at t( 9;22 ) breakpoint are common and may identify a poor prognosis subgroup of patients with CML. Blood 2000 95(3):738-44.
- Kolomietz E, Al-Magharabi J, Brennan S., Karaskova J, Minkin S, Lipton J, Squire J. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis Blood 2001 97(11):3581-88.
- Huntly B, Reid A, Bench A, Campbell L, Telford N Shepherd P et al Deletions of the derivative chromosome 9 occur at the time of the philadelphia translocation and provide a powerful and independent prognostic indicator in CML Blood 2001 98(6):1732-8.
|
|
|
©
Está
expresamente prohibida la redistribución y la redifusión de todo o parte de los
contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin
previo y expreso consentimiento de SIIC. |
|
|